Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Pirinitramide × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡